SDIX's Q4 Revenues, Loss Decline

Feb 25, 2010

NEW YORK (GenomeWeb News) – SDIX, the firm previously known as Strategic Diagnostics, reported after the close of the market Thursday that its fourth-quarter revenues fell 11 percent, but the firm managed to cut its loss to almost zero for the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Hackers Go After Genome Data

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

What's This Personalized Medicine?

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

No Gene Drive Ban

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

This Week in Science

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Featured White Papers

Potential Pitfalls to Life Science Product Launch

Freeze-drying - a manufacturing approach to increase the stability of in vitro diagnostic (IVD) assays

Dec

11

Featured Webinar

Assessing the Impact of Different Aneuploid Findings with Independent NGS Platforms

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.

Dec

12

Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

Main menu